Alahednews
english.alahednews.com.lb
Resistance and Liberation 2017
Sayyed Nasrallah Advises Saudis to Talk to Iran: We're Stronger than Ever Trump: N. Korea Problem 'Will Be Solved' SOS Mystery Puzzles Australian Police France Vows to Help Britain Fight Terror Activists Urge International Action against Al Khalifah Regime US Appeals Court Refuses To Reinstate Travel Ban Qassemi: Iran to Keep Up Missile Work with Utmost Power UK Hospitals 'Told To Prepare For Bank Holiday Terror Attack' Bahrain Crackdown: More Anti-regime Rallies Nationwide after Diraz Massacre Corbyn to Blame Terrorist Attacks on UK's Foreign Policy Eyewitnesses: Gunmen Attack #Coptic Christians in #Egypt #Indonesia Arrests 3 Suspects in Bombings that Killed Police Families of #Diraz Martyrs: We Identified Their Bodies #Saudi Ratifies Sentence to Execute 14 Citizens from #Qatif #Diraz: Regime Summons Families of Fida'a Square Martyrs #Philippines: Foreign Fighters Part of #Daesh 'Invasion' #Awamia: #Saudi Special Forces Strom the Town in Civil Clothes, Vehicles #Awamia: Residents of Bahari, Qadih break Separation Wall #Awamia: #Saudi Forces Demolish Imam Ali [AS] Street #Awamia: Saudi Forces Shoot Rif Neighborhood, Bomb #Mosawara
Guestbook mailinglist.php arabic site french site spanish site facebook twitter rss page
News Categories » NEWS » Miscellaneous

Decrease Font Size Increase Font Size  Print Page
WHO Urges Action over Growing Hepatitis Epidemic
Local Editor

The number of people dying from hepatitis is rising, and most of the 325 million infected are unaware they have the virus and lack access to potentially life-saving medicines, the World Health Organization said Friday.

WHO Urges Action over Growing Hepatitis Epidemic

In its first global report on the infection, the WHO said that with millions at risk of a slow progression to chronic liver disease, cancer and premature death, swift action on testing and treatment was needed.

"Viral hepatitis is now a major public health challenge that requires an urgent response," the WHO's Director General Margaret Chan said in a statement.

The 325 million cases reported are of hepatitis B [HBV] or hepatitis C virus [HCV] - the main types of the five different hepatitis infections and responsible for 96 percent of deaths from the disease.

HBV infection requires lifelong treatment, for which the WHO recommends tenofovir, a generic anti-viral drug also used in HIV treatment.

Hepatitis C can be cured relatively swiftly, but the medicines are too expensive for many patients.

Pressure over pricing has been growing, notably on US manufacturer Gilead Sciences - which has developed some of the most effective treatments - and the company has taken some steps to offer discounts and provide access programs.

That includes allowing Indian drug makers to manufacture much lower-cost versions of them for sale in developing countries.

Gottfried Hirnschall, director of WHO's Department of HIV and the Global Hepatitis Program, said the WHO was working with governments, drug makers and diagnostics companies to improve access.

"More countries are making hepatitis services available for people in need - a diagnostic test costs less than $1 and the cure for hepatitis C can be below $200," he said. "But the data clearly highlight the urgency with which we must address the remaining gaps in testing and treatment."

Viral hepatitis killed 1.34 million people in 2015, a toll comparable to tuberculosis and HIV/AIDS. But while TB and AIDS deaths are falling, hepatitis deaths are on the rise and have increased by 22 percent since 2000, the WHO said.

Source: News Agencies, Edited by website team

 

21-04-2017 | 13:16


Name
E-Mail
Comment Title
Comment
Validtion Image


News Coverage

Related News

Search
To Top